Weiss Multi-Strategy Advisers LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 217 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$1,073,000
+17.9%
30,000
-14.3%
0.04%
+68.2%
Q3 2014$910,000
-49.9%
35,000
-36.4%
0.02%
-45.0%
Q2 2014$1,818,000
+5.6%
55,000
-4.4%
0.04%
+14.3%
Q1 2014$1,722,000
-49.1%
57,520
-48.4%
0.04%
-52.1%
Q4 2013$3,384,000
-11.4%
111,460
-7.1%
0.07%
+78.0%
Q3 2013$3,818,000
+260.9%
120,000
+71.4%
0.04%
+32.3%
Q2 2013$1,058,00070,0000.03%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders